ER 49 articles written Emma Ryan Latest Articles Type 1 & Type 2 FDA to Review Possible Amputation Risk with Invokana and Invokamet new now next Read more FDA to Review Possible Amputation Risk with Invokana and Invokamet Type 1 & Type 2 FDA Approves New Treatment for Diabetic Foot Ulcers new now next Read more FDA Approves New Treatment for Diabetic Foot Ulcers Type 1 & Type 2 Updates on Harvard’s Diabetes Stem Cell Research from ADA 2015 new now next Read more Updates on Harvard’s Diabetes Stem Cell Research from ADA 2015 Type 1 & Type 2 FDA Approves Innovative Breath Test to Diagnose Gastroparesis new now next Read more FDA Approves Innovative Breath Test to Diagnose Gastroparesis Type 1 & Type 2 Spotlight on Eylea: The Second FDA-Approved Eye Medication for Diabetic Retinopathy new now next Read more Spotlight on Eylea: The Second FDA-Approved Eye Medication for Diabetic Retinopathy Type 1 & Type 2 Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life new now next Read more Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life Type 1 & Type 2 Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease new now next Read more Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease Type 1 & Type 2 Toujeo Launches in the US – The Next Generation Lantus new now next Read more Toujeo Launches in the US – The Next Generation Lantus Type 1 & Type 2 FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi new now next Read more FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi Pages« first ‹ previous 1 2 3 4 5
Type 1 & Type 2 FDA to Review Possible Amputation Risk with Invokana and Invokamet new now next Read more FDA to Review Possible Amputation Risk with Invokana and Invokamet
Type 1 & Type 2 FDA Approves New Treatment for Diabetic Foot Ulcers new now next Read more FDA Approves New Treatment for Diabetic Foot Ulcers
Type 1 & Type 2 Updates on Harvard’s Diabetes Stem Cell Research from ADA 2015 new now next Read more Updates on Harvard’s Diabetes Stem Cell Research from ADA 2015
Type 1 & Type 2 FDA Approves Innovative Breath Test to Diagnose Gastroparesis new now next Read more FDA Approves Innovative Breath Test to Diagnose Gastroparesis
Type 1 & Type 2 Spotlight on Eylea: The Second FDA-Approved Eye Medication for Diabetic Retinopathy new now next Read more Spotlight on Eylea: The Second FDA-Approved Eye Medication for Diabetic Retinopathy
Type 1 & Type 2 Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life new now next Read more Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life
Type 1 & Type 2 Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease new now next Read more Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
Type 1 & Type 2 Toujeo Launches in the US – The Next Generation Lantus new now next Read more Toujeo Launches in the US – The Next Generation Lantus
Type 1 & Type 2 FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi new now next Read more FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi